As well as being based on a particular ingredient formulation, NUQO SAFE relies on a new double encapsulation approach, said the producer.
The technology includes a combination of phytogenics and phycogenics – active molecules from plants and algae – that reportedly have a proven effect on digestibility and immunity, and organic acids that are said to have stabilizing effects on gut microflora.
NUQO R&D director, Dr Stéphanie Ladirat, says the double encapsulation method enables, not just a slow release, but an accurate and precise controlled released of ingredients to support gut health. The idea is that active compounds are released specifically between the duodenum up to the colon, with fractionated or sequenced release of the different ingredients, so that every compound gets released on spot to enhance digestive functions and control gut microflora.
The technology is designed to address three main objectives:
- Support digestive functions
- Trigger antioxidant effect and immune modulation
- Ensure pathogen control
The phycogenics in the product are derived from brown algae (Ascophyllum), which NUQO says it harvests and processes in a way to obtain a high concentration of metabolites. The phytogenics are produced from compounds such as thyme, oregano, cinnamon and chili, confirmed Ewenn Helary, CEO of NUQO.
Market authorization
NUQO SAFE is authorized already in EU and US, and in some countries in Latin America and Asia, while pending in other markets.
NUQO zoning in on monogastric gut health with new double encapsulation plant based technology - FeedNavigator.com
Read More
No comments:
Post a Comment